{
    "clinical_study": {
        "@rank": "129403", 
        "arm_group": {
            "arm_group_label": "Healthy Normals"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the feasibility and accuracy of an automated\n      adherence monitoring system, and to compare the variance between urine and oral fluid\n      riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen\n      interval."
        }, 
        "brief_title": "Adherence Monitoring For Substance Abuse Clinical Trials", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Medication Adherence", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, aged 18 to 60\n\n          -  Ability to give informed consent.\n\n          -  Be willing and able to use the study-provided phone for taking and transmitting\n             capsule photos.\n\n        Exclusion Criteria:\n\n          -  Unwilling or unable to use a cell phone.\n\n          -  Any medical, psychiatric, or other condition that, in the opinion of the\n             investigator, would preclude safe, consistent, or useful participation in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Healthy Normals"
            }
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01867476", 
            "org_study_id": "2012.075EXP"
        }, 
        "intervention": {
            "arm_group_label": "Healthy Normals", 
            "intervention_name": "Automated Adherence Monitoring System", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "San Francisco", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94110"
                }, 
                "name": "Addiction & Pharmacology Research Lab, St. Luke's Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "overall_official": {
            "affiliation": "California Pacific Medical Center", 
            "last_name": "John Mendelson, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval", 
            "safety_issue": "No", 
            "time_frame": "+ 1, 2, 3, 4, 6 hours post dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01867476"
        }, 
        "responsible_party": {
            "investigator_affiliation": "California Pacific Medical Center Research Institute", 
            "investigator_full_name": "John Mendelson, MD", 
            "investigator_title": "Senior Scientist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "California Pacific Medical Center Research Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "Creare, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "California Pacific Medical Center Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}